At Touchlight we are revolutionising DNA.
Our Company and technology is built on the conviction that DNA is fundamental to the future of medicine.
By moving away from today's restrictive biological approaches, we have made DNA simple. Our unique dbDNA™ (or "doggybone" DNA) vector is optimised for use in advanced genetic medicines, being safer and more efficacious than conventional plasmid DNA. The platform, based on enzymatic technology, enable DNA production at unprecedented scale, speed and purity.
We are leveraging our platform to develop the next generation of DNA vaccines for oncology and infectious diseases, in house and in collaboration with industry partners and academics, as well as enabling manufacture of advanced therapies (viral vectors, mRNA vaccines, and cell therapies) through our CDMO, Touchlight DNA Services.
For more information please visit our website or get in touch by emailing info@touchlight.com.
Member count: 51-200
Founded date: 2008
Investors 1
| Date | Name | Website |
| 31.08.2021 | Novator Pa... | novator.co... |
Mentions in press and media 22
| Date | Title | Description | Category | Author | Source |
| 01.12.2022 | Touchlight... | Touchlight, a London, UK-based... | UK | - | finsmes.co... |
| 14.11.2022 | AAV Manufa... | This includes slow or delayed ... | - | - | prweb.com/... |
| 08.03.2022 | With inves... | Butts, bums and booties star i... | - | Josh Sulli... | endpts.com... |
| 08.03.2022 | With inves... | For bluebird bio, the FDA’s ve... | - | Josh Sulli... | endpts.com... |
| 08.03.2022 | BioNTech a... | There was a single question co... | - | Max Gelman | endpts.com... |
| 08.03.2022 | Kurma scor... | Biogen CEO Michel Vounatsos is... | Financing | Paul Schlo... | endpts.com... |
| 08.03.2022 | BioNTech a... | Whatever Voyager is coming up ... | - | Max Gelman | endpts.com... |
| 08.03.2022 | BioNTech a... | After going back to the negoti... | - | Max Gelman | endpts.com... |
| 08.03.2022 | With inves... | In an ideal scenario, Mytide T... | - | Josh Sulli... | endpts.com... |
| 08.03.2022 | With inves... | First approved by the FDA in 2... | - | Josh Sulli... | endpts.com... |
Show more